Lisa Hark

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
PURPOSE Patients with glaucoma who do not keep their follow-up eye care appointments are at risk for developing more severe ocular disease. The primary aim of the current study was to evaluate whether the use of a patient navigator altered adherence to follow-up eye care appointments in community-versus office-based settings. PATIENTS AND METHODS Patients(More)
PURPOSE To utilize the Travoprost Dosing Aid (DA) in the assessment of patient medication adherence, while also determining whether or not altering the functionality of the DA in three randomized subject groups can reduce observer effect. METHODS Forty-five subjects were randomized into three groups: two with monitored DAs and one without monitoring. One(More)
PURPOSE To evaluate the interest of glaucoma patients and their caregivers in a smartphone-based and tablet-based glaucoma application (App), developed by the Wills Eye Glaucoma Research Center in collaboration with Drexel University. MATERIALS AND METHODS Cross-sectional survey of patients with glaucoma and their caregivers. Main outcome measures are(More)
I n 2010, participants at the National Eye Institute-Food and Drug Administration Glaucoma Clinical Design and Endpoints Symposium (NEI-FDA) discussed the adoption of new endpoint measures for assessing glaucoma therapies in clinical trials. Currently, the FDA generally accepts IOP and visual field (VF) endpoints for evaluating new treatments for glaucoma.(More)
  • 1